Preclinical Respiratory Research

Lovelace Biomedical has been recognized as a world leader in conducting respiratory pharmacology and toxicology studies for more than 40 years. Expertise includes the development of new respiratory therapies, new animal models of respiratory diseases, the conduct of IND and NDA enabling toxicology studies and the merger of respiratory models/toxicology with larger programs.

Inhalation Toxicology

Lovelace Biomedical conducts a full range of GLP and non-GLP inhalation studies. We are known worldwide for our storied and long history in the field of inhalation toxicology. We integrate quality, leading-edge expertise in generation and characterization of exposure atmospheres, exposure technology, dosimetry, and evaluation of health outcomes to quickly meet study goals. Lovelace’s state of the art inhalation toxicology facility has capabilities and capacity to conduct single or repeated, nose-only or whole-body inhalation exposures of all laboratory species.

In Vivo Pharmacology

Preclinical Pharmacology Research – Lovelace Biomedical’s scientists are experts in more than 100 animal models of disease, encompassing both large and small animals. Expert biologists, engineers, chemists, statisticians, and technical staff, are available to support preclinical studies evaluating safety and efficacy. Our scientists bring extensive experience in a wide range of small- and large-molecule delivery methods, including specialty routes, and studies can be supported by our additional expertise in pharmacokinetics, analytical chemistry, toxicology and pathology.